Neenah's Ayurvedic-Life International Inks Licensing Deal with East India Pharmaceutical Works

Neenah, Wis. (Dec. 21, 2007) — East India Pharmaceutical Works (EIPW) Ltd., Kolkata, India, has licensed two patents from Ayurvedic-Life International, LLC, a Neenah-based research and development company focused on phytopharmacological applications. The agreement will enable EIPW to extend its presence in the diabetes health care market in India.

“We are excited about being able to deliver a novel ayurvedic-based product into the Indian market based on our licensing agreement with Ayurvedic-Life,” said Dipankar Dutta Gupta, managing director of EIPW Ltd.

In 2000, the World Health Organization estimated that nearly 32 million people in India had diabetes. Officials with WHO estimate that will increase to 79 million people by 2030.

“We are pleased to enter into this licensing arrangement with EIPW, and our commitment to developing nature's gifts into compounds to help millions of people live healthier lives is reflected in our agreement with EIPW,” said Arun K. Chatterji, Ph.D., chairman and CEO of Ayurvedic-Life International, LLC.

###

Located in Neenah, Wis., Ayurvedic-Life International, LLC is a research and development company focused on phytopharmacological applications. Media contact Jennifer Walla, Ideas That Deliver, (920) 722-4014 or jenniferw@ideasthatdeliver.com.

Based in Kolkata, India, East India Pharmaceutical Works Ltd. has three manufacturing units, a work force of 1,500 employees and an annual turnover of approximately Rs. 800 million. EIPW is ISO 9001-2000 certified.